-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Lexaria Bioscience Corp. quarterly/annual Revenues history and growth rate from Q1 2016 to Q2 2025.
- Lexaria Bioscience Corp. Revenues for the quarter ending May 31, 2025 was $174K, a 107% increase year-over-year.
- Lexaria Bioscience Corp. Revenues for the twelve months ending May 31, 2025 was $616K, a 49.9% increase year-over-year.
- Lexaria Bioscience Corp. annual Revenues for 2024 was $464K, a 105% increase from 2023.
- Lexaria Bioscience Corp. annual Revenues for 2023 was $226K, a 11.4% decline from 2022.
- Lexaria Bioscience Corp. annual Revenues for 2022 was $255K, a 64.7% decline from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)